Zobrazeno 1 - 10
of 13
pro vyhledávání: '"V A Boussiotis"'
Autor:
Steven L. McAfee, Robert J. Soiffer, Thomas R. Spitzer, Ioannis Politikos, Karen K. Ballen, Joseph H. Antin, Katarzyna Jamieson, John R. Wingard, Ram Kamble, Adam Mendizabal, Eyal C. Attar, John Koreth, V. A. Boussiotis, Vincent T. Ho, Bimalangshu R. Dey, Richard T. Maziarz, Philip L. McCarthy, Corey Cutler, Colleen Delaney, Edwin P. Alyea, Edward D. Ball, David Avigan, Elizabeth J. Shpall
Publikováno v:
Biology of Blood and Marrow Transplantation. 18(12):1851-1858
Transplantation of one or two umbilical cord blood products is a useful alternative stem cell source. However, the limited number of stem cells in the infusion results in slow engraftment. In mouse models, administration of parathyroid hormone is an
Publikováno v:
The Journal of Immunology. 159:3156-3167
Since TCR-mediated stimulation induces T cells to become sensitive to Fas-mediated activation-induced cell death (Fas-AICD), we examined whether anergized and CD28-costimulated T cell clones were equally sensitive to Fas-AICD. Here, we show that TCR
Publikováno v:
Blood. 84:3261-3282
The above story illustrates the translation of basic scientific discoveries to the clinic. In vitro and preclinical in vivo experimentation suggests that modulation of the B7:CD28 pathway will result in either amplification or suppression of the immu
Autor:
T P, Vassilakopoulos, M K, Angelopoulou, M P, Siakantaris, F N, Kontopidou, M N, Dimopoulou, A, Barbounis, V, Grigorakis, C, Karkantaris, K, Anargyrou, M, Chatziioannou, J, Rombos, V A, Boussiotis, G, Vaiopoulos, C, Kittas, G A, Pangalis
Publikováno v:
European journal of haematology. 67(5-6)
Advanced Hodgkin's lymphoma (HL) is curable by conventional chemotherapy in 60--70% of patients. The pretreatment identification of a sizeable subgroup of patients with sufficiently low failure-free survival (FFS) to be eligible for investigational t
Publikováno v:
Seminars in hematology. 36(2)
Treatment of low-grade lymphoma and chronic lymphocytic leukemia (CLL) is a challenge for hematologists. The long physical history and the indolent nature of these diseases do not support the choice of aggressive treatment. However, regardless of the
Autor:
G J, Freeman, A A, Cardoso, V A, Boussiotis, A, Anumanthan, R W, Groves, T S, Kupper, E A, Clark, L M, Nadler
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 161(6)
The identification of all CD28/CTLA-4 counterreceptors is critical to our understanding of this pivotal pathway of T cell activation. Clouding our understanding has been the reported discrepancies in expression and function of the B7-1 (CD80) molecul
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 159(7)
Since TCR-mediated stimulation induces T cells to become sensitive to Fas-mediated activation-induced cell death (Fas-AICD), we examined whether anergized and CD28-costimulated T cell clones were equally sensitive to Fas-AICD. Here, we show that TCR
Autor:
J G, Gribben, E C, Guinan, V A, Boussiotis, X Y, Ke, L, Linsley, C, Sieff, G S, Gray, G J, Freeman, L M, Nadler
Publikováno v:
Blood. 87(11)
Graft-versus-host disease (GVHD) is initiated by adoptively transferred donor T cells that recognize host alloantigens. Whereas the absence of donor T-cell proliferation to host alloantigens in a mixed-leukocyte reaction does not predict freedom from
Publikováno v:
Seminars in oncology. 20(6)
Autor:
G A, Pangalis, V A, Boussiotis, C, Kittas, P G, Panayiotidis, D, Loukopoulos, P, Fessas, C, Mitsoulis-Mentzikoff
Publikováno v:
Blood. 78(5)